Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

A triple-board-certified MD of lifestyle and obesity medicine lists the foods that will optimize your medication's efficacy ...

A clear FDA public education campaign could help shoppers make healthier choices. But it should first pay attention to the ...

More than 30,000 people were admitted to hospital with obesity in Hampshire last year, new figures show. It comes as the ...

Most telling though, the results that show that the overall obesity rate in the U.S. has not changed significantly in a ...

Researchers assess the role of liraglutide in regulating iron metabolism in a mouse model of hereditary hemochromatosis.

ED is a medical condition in which you regularly have trouble getting or maintaining an arousal firm enough for satisfying ...